Your browser doesn't support javascript.
loading
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Infante, Jeffrey R; Reid, Tony R; Cohn, Allen L; Edenfield, William J; Cescon, Terrence P; Hamm, John T; Malik, Imtiaz A; Rado, Thomas A; McGee, Philip J; Richards, Donald A; Tarazi, Jamal; Rosbrook, Brad; Kim, Sinil; Cartwright, Thomas H.
  • Infante JR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee, USA. jinfante@tnonc.com
Cancer ; 119(14): 2555-63, 2013 07 15.
Article en En | MEDLINE | ID: mdl-23605883

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2013 Tipo del documento: Article